Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group.
Mélanie CalmelsCamélia LabiadBernard LelongJérémie H LefevreJean-Jacques TuechStéphane BenoistDiane MègeQuentin DenostYves PanisPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)
TME remains the gold standard for mid/low rectal cancer after CRT. LE in selected patients is safe for operative and functional, but also oncological, results. However, completion TME was indicated in 42% of patients after LE, highlighting the difficulty of the preoperative diagnosis of CTR after CRT.